About Omass
Omass is a company based in Oxford (United Kingdom) founded in 2016 by Jonathan Hopper and Idlir Liko was acquired by Syncona in November 2018.. Omass has raised $19.32 million across 2 funding rounds from investors including Syncona and Oxford Science Enterprises. The company has 39 employees as of December 31, 2021. Omass operates in a competitive market with competitors including Evelo Biosciences, PathogenDX, Phylos Bioscience, AFYREN and Crawford Scientific, among others.
- Headquarter Oxford, United Kingdom
- Employees 39 as on 31 Dec, 2021
- Founders Jonathan Hopper, Idlir Liko
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Omass Therapeutics Limited
- Date of Incorporation 26 Feb, 2016
- Jurisdiction OXFORD, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Omass
Omass has successfully raised a total of $19.32M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $17.9 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $17.9M
-
First Round
First Round
(14 Jun 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Series A - Omass | Valuation | Syncona , Oxford Science Enterprises |
|
| Jun, 2016 | Amount | Seed - Omass | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Omass
Omass has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Syncona and Oxford Science Enterprises. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are managed via private equity by Syncona.
|
Founded Year | Domain | Location | |
|
Investment management services for science ventures are provided in Oxford.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Omass
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Omass
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Omass Comparisons
Competitors of Omass
Omass operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, PathogenDX, Phylos Bioscience, AFYREN and Crawford Scientific, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provider of DNA-based pathogen testing kits
|
|
| domain | founded_year | HQ Location |
Developer of cannabis breeding tools for agriculture & other health purposes
|
|
| domain | founded_year | HQ Location |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| domain | founded_year | HQ Location |
Service provider in analytical testing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Omass
Frequently Asked Questions about Omass
When was Omass founded?
Omass was founded in 2016.
Where is Omass located?
Omass is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Omass a funded company?
Omass is a funded company, having raised a total of $19.32M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.42M, raised on Jun 14, 2016.
How many employees does Omass have?
As of Dec 31, 2021, the latest employee count at Omass is 39.
What does Omass do?
Omass was established in 2016 in Oxford, United Kingdom, as a service provider in the pharmaceutical and research sectors. Native mass spectrometry is applied by the company to characterize intact protein assemblies, supporting drug discovery processes. Solutions are delivered through this specialized platform to clients in these industries, with operations focused on analytical services for protein-based research and development.
Who are the top competitors of Omass?
Omass's top competitors include PathogenDX, AFYREN and Perfectus Biomed.
Who are Omass's investors?
Omass has 2 investors. Key investors include Syncona, and Oxford Science Enterprises.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.